
Osteoarthritis
No difference between diclofenac & paracetamol in pain management for knee osteoarthritis
Br J Gen Pract. 2015 Aug;65(637):e530-7.104 patients with symptomatic knee osteoarthritis were randomized to receive either paracetamol or diclofenac, a type of non-steroidal anti-inflammatory drug (NSAID). The purpose of this open-labelled study was to compare the two drugs to determine if one had a greater effectiveness over the course of a 12 week follow-up period. Results indicated that there were no significant differences in clinical outcomes between the groups, in terms of pain and function improvement.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.